Drug intelligence / Profile preview

diclofenac sodium + misoprostol

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

This is a fixed-dose combination drug consisting of **diclofenac sodium**, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties, and **misoprostol**, a synthetic prostaglandin E1 analog with gastroprotective effects. Diclofenac inhibits the enzyme cyclooxygenase (COX), reducing the synthesis of prostaglandins that mediate inflammation and pain. Misoprostol protects the gastric and duodenal mucosa by replacing prostaglandins depleted by NSAIDs, decreasing gastric acid secretion, and increasing mucus and bicarbonate secretion. The combination is primarily indicated to treat osteoarthritis and rheumatoid arthritis in patients at high risk of developing NSAID-induced gastric or duodenal ulcers[2][3][5][7][9][10][12].

Brand names
Arthrotec
Other names
diclofenac/misoprostoldiclofenac sodium and misoprostoldiclofenac sodium with misoprostol
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PTGER (Prostaglandin E2 receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac sodium + misoprostol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac sodium + misoprostol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call